Pyomyositis in Children: A 15-year Retrospective Study From a Tertiary Care Pediatric Hospital in Portugal

Vitória Cadete1, Susana Norte2, Joana Arcângelo2

  • 1From the Pediatric Department.

Insights

Pyomyositis, a muscle infection, often presents with nonspecific symptoms. This study found that many children with pyomyositis, even in the suppurative phase, can recover with conservative antibiotic treatment, avoiding surgical drainage.

Area of Science:

  • Pediatric Infectious Diseases
  • Musculoskeletal Infections
  • Clinical Microbiology

Background:

  • Pyomyositis is a primary skeletal muscle infection, predominantly seen in children in tropical regions.
  • Current treatment paradigms often involve antibiotics and surgical drainage, though this remains a subject of debate.

Purpose of the Study:

  • To analyze predisposing factors, clinical presentation, diagnostic findings, treatment strategies, and outcomes of pediatric pyomyositis.
  • To evaluate the efficacy of conservative management versus surgical intervention in pyomyositis cases.

Main Methods:

  • A retrospective, single-center study was conducted over 15 years (2008-2022) at a pediatric tertiary care hospital.
  • Data collected included patient demographics, predisposing factors, clinical signs, laboratory results, imaging, treatment details, and follow-up assessments.

Main Results:

  • Twenty-nine pediatric patients were included, with intense physical activity and trauma as common triggers.
  • Methicillin-sensitive Staphylococcus aureus was the most frequent pathogen. Conservative treatment with intravenous antibiotics was successful in most cases, with drainage reserved for a minority.
  • Magnetic resonance imaging demonstrated high sensitivity (100%) for diagnosis, while ultrasound results were inconclusive in over 40% of cases.

Conclusions:

  • Pediatric pyomyositis can manifest with nonspecific symptoms, necessitating a high index of suspicion.
  • Conservative management, including antibiotics without drainage, is a viable option for many pyomyositis cases, including those in the suppurative stage.
  • Methicillin-sensitive Staphylococcus aureus is the predominant causative agent, guiding antibiotic selection.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...